Clinical Trial Update: Efficacy of Repaglinide in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports the efficacy findings of repaglinide in subjects with type 2 diabetes, and indicates the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED